Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Judson

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Role of expert centres in the management of sarcomasIan Judson
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
In relation to Anninga et al. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomasIan Judson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2012
Therapeutic drug monitoring of imatinib--new data strengthen the caseIan Judson
Current Opinion in Oncology|June 6, 2008
Imatinib in advanced gastrointestinal stromal tumour: when is 800 mg the correct dose?Ian Judson
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
New treatments for sarcomaIan Judson
Gynecologic Oncology Reports|December 28, 2020
Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literatureIan Judson, Christina Messiou
Journal of Oncology Practice|March 11, 2016
Systemic Treatment of Liposarcomas: Light at the End of the Tunnel?Anastasia Constantinidou, Ian Judson
Hematology/Oncology Clinics of North America|June 9, 2005
Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomasMichelle Scurr, Ian Judson
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
SarcomaMichelle Scurr, Ian Judson
Archives of Toxicology|July 1, 2011
The safety profile of imatinib in CML and GIST: long-term considerationsEirini Thanopoulou, Ian Judson
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Role of expert centres in the management of sarcomasIan Judson
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
In relation to Anninga et al. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomasIan Judson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2012
Therapeutic drug monitoring of imatinib--new data strengthen the caseIan Judson
Current Opinion in Oncology|June 6, 2008
Imatinib in advanced gastrointestinal stromal tumour: when is 800 mg the correct dose?Ian Judson
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
New treatments for sarcomaIan Judson
Gynecologic Oncology Reports|December 28, 2020
Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literatureIan Judson, Christina Messiou
Journal of Oncology Practice|March 11, 2016
Systemic Treatment of Liposarcomas: Light at the End of the Tunnel?Anastasia Constantinidou, Ian Judson
Hematology/Oncology Clinics of North America|June 9, 2005
Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomasMichelle Scurr, Ian Judson
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
SarcomaMichelle Scurr, Ian Judson
Archives of Toxicology|July 1, 2011
The safety profile of imatinib in CML and GIST: long-term considerationsEirini Thanopoulou, Ian Judson
Pageof 16